NATIONS FINANCIAL GROUP INC, /IA/ /ADV
Position in GILD — Gilead Sciences, Inc.
CIK 1109767
CEDAR RAPIDS, IA
Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$853,174
-$98,444 QoQ
Shares Held
6,753
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,146
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $42,950,041 across 11 Drug Manufacturers - General names. GILD ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,271 | $13,518,776 | |
| 2 | JNJ |
Johnson & Johnson
|
37,265 | $9,464,192 | |
| 3 | AMGN |
Amgen Inc
|
16,562 | $5,997,431 | |
| 4 | ABBV |
AbbVie Inc.
|
21,335 | $5,368,739 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,911 | $3,072,563 | |
| 6 | PFE |
Pfizer Inc
|
71,165 | $1,713,653 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,741 | $1,137,476 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
6,753 | $853,174 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $853,174 | 6,753 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $951,618 | 6,828 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $818,675 | 6,670 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $733,932 | 6,612 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $731,298 | 6,596 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $694,149 | 6,195 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $769,442 | 8,330 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $708,196 | 8,447 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $386,548 | 5,634 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $371,743 | 5,075 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $410,396 | 5,066 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $384,292 | 5,128 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $472,439 | 6,130 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $478,073 | 5,762 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $472,260 | 5,501 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $211,781 | 3,433 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $221,156 | 3,578 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $249,452 | 4,196 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $225,454 | 3,105 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $229,108 | 3,280 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $267,521 | 3,885 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $204,166 | 3,159 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $239,363 | 3,788 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $314,376 | 4,086 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $608,621 | 8,141 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||